These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12564978)

  • 21. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
    Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new platform for oligonucleotide delivery utilizing the PEG prodrug approach.
    Zhao H; Greenwald RB; Reddy P; Xia J; Peng P
    Bioconjug Chem; 2005; 16(4):758-66. PubMed ID: 16029016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEG prodrugs of 6-mercaptopurine for parenteral administration using benzyl elimination of thiols.
    Choe YH; Greenwald RB; Conover CD; Zhao H; Longley CB; Guan S; Zhao Q; Xia J
    Oncol Res; 2004; 14(9):455-68. PubMed ID: 15490977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
    Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
    J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives.
    Arpicco S; Stella B; Schiavon O; Milla P; Zonari D; Cattel L
    Int J Pharm; 2013 Oct; 454(2):653-9. PubMed ID: 23701999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegnology: a review of PEG-ylated systems.
    Bhadra D; Bhadra S; Jain P; Jain NK
    Pharmazie; 2002 Jan; 57(1):5-29. PubMed ID: 11836932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature.
    Chen Y; Zhang M; Jin H; Tang Y; Wang H; Xu Q; Li Y; Li F; Huang Y
    Biomaterials; 2017 Feb; 116():57-68. PubMed ID: 27914267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery systems based on trimethyl lock lactonization: poly(ethylene glycol) prodrugs of amino-containing compounds.
    Greenwald RB; Choe YH; Conover CD; Shum K; Wu D; Royzen M
    J Med Chem; 2000 Feb; 43(3):475-87. PubMed ID: 10669575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
    Zhao H; Rubio B; Sapra P; Wu D; Reddy P; Sai P; Martinez A; Gao Y; Lozanguiez Y; Longley C; Greenberger LM; Horak ID
    Bioconjug Chem; 2008 Apr; 19(4):849-59. PubMed ID: 18370417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
    Li M; Liang Z; Sun X; Gong T; Zhang Z
    PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
    Pendri A; Conover CD; Greenwald RB
    Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate.
    Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives.
    Greenwald RB; Zhao H; Yang K; Reddy P; Martinez A
    J Med Chem; 2004 Jan; 47(3):726-34. PubMed ID: 14736253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prodrugs: Some thoughts and current issues.
    Stella VJ
    J Pharm Sci; 2010 Dec; 99(12):4755-65. PubMed ID: 20821387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
    Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2001 Oct; 90(10):1628-36. PubMed ID: 11745721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel intravenous vehicle for preclinical cardiovascular screening of small molecule drug candidates in rat.
    Banfor PN; Gintant GA; Lipari JM; Zocharski PD
    J Pharmacol Toxicol Methods; 2016; 82():62-67. PubMed ID: 27432021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel prospective in colon specific drug delivery system.
    Bansal V; Malviya R; Malaviya T; Sharma PK
    Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.